Description

Priorix is a lyophilised mixed preparation of the attenuated Schwarz measles, RIT 4385 mumps (derived from Jeryl Lynn strain) and Wistar RA 27/3 rubella strains of viruses, separately obtained by propagation either in chick embryo tissue cultures (mumps and measles) or MRC-5 human diploid cells (rubella).
Priorix meets the World Health Organisation requirements for manufacture of biological substances and for measles, mumps and rubella vaccines and combined vaccines (live).
Each 0.5 ml dose of the reconstituted vaccine contains not less than 103.0 CCID50 of the Schwarz measles, not less than 103.7 of the RIT 4385 mumps, and not less than 103.0 CCID50 of the Wistar RA 27/3 rubella virus strains.
Excipients/Inactive Ingredients: Excipients of the vaccine are: amino acids, lactose, mannitol, sorbitol.
Solvent: Water for injections.
Neomycin sulphate is present as a residual from the manufacturing process.